Medical Sources
Every claim Pureami Tea Company makes is grounded in published, peer-reviewed medical literature. Below are the sources — all available free at PubMed.com.
Our Commitment to Transparency
The three names — Myricetin, DiHydroMyricetin, and Ampelopsin — all refer to the same flavonol. Search any of them on PubMed.com and you will find a substantial body of evidence. Qing Yun Moyeam produces this compound at 30–40% by plant weight, versus 3–6% for ordinary grades.
We do not cherry-pick studies. We have never made a claim not supported by the published literature. All citations below link directly to their source on PubMed or the original journal.
Showing moyeam. Clear filter
Qing Yun Moyeam
Ampelopsis Grossedentata — Myricetin / DiHydroMyricetin / Ampelopsin
Anti-Inflammatory
PubMed
Myricetin protected heart muscle cells from inflammatory injury, suggesting a role in reducing cardiac inflammation.
PubMed
Dihydromyricetin (Myricetin) was shown to suppress joint inflammation in arthritis by blocking a key inflammatory signaling pathway.
PubMed
A broad review of Myricitrin (a form of Myricetin) documenting its wide-ranging anti-inflammatory and antioxidant molecular effects throughout the body.
PubMed
A myricetin-derived compound demonstrated strong effectiveness in reducing chronic colon inflammation, pointing to Myricetin's therapeutic potential for inflammatory bowel conditions.
PubMed
Using advanced gene-expression analysis, this study mapped the specific proteins and pathways through which myricetin delivers its anti-inflammatory effects.
PubMed
Demonstrated significant anti-inflammatory activity in a myricetin-rich plant extract tested in animal models.
PubMed
Myricetin was shown to reduce severe tissue inflammation and repair biological barriers damaged by inflammatory insult.
PubMed
Myricetin suppressed the skin-based inflammatory responses that drive acne, supporting its use in skin health applications.
Atherosclerosis / Vascular Health
PubMed
Dihydromyricetin from Moyeam was found to protect blood vessels from the abnormal tissue buildup that contributes to arterial narrowing and heart disease.
PubMed
Dihydromyricetin protected the inner lining of blood vessels from inflammation-induced dysfunction, a key factor in cardiovascular disease.
PubMed
Dihydromyricetin reduced the formation of "foam cells" — the cholesterol-laden cells that build up in arteries and drive atherosclerosis.
PubMed
In an animal model of atherosclerosis, Dihydromyricetin significantly reduced arterial plaque development, demonstrating a direct anti-atherosclerotic effect.
Anti-Cancer (General)
PubMed
Myricetin demonstrated a significant protective effect against chemically-induced breast cancer in animal models, reducing tumor development.
PubMed
Myricetin was shown to stabilize a specific DNA structure (G-quadruplex) that helps suppress cancer cell replication — revealing a novel anticancer mechanism.
PubMed
This structural study showed how myricetin binds to and inhibits a bacterial protein involved in DNA replication, with implications for targeting similar pathways in cancer cells.
PubMed
Myricetin was found to block multiple enzymes (kinases) that drive tumor growth, suggesting broad-spectrum anticancer potential across several cancer types.
Triple Negative Breast Cancer
PubMed
Myricetin selectively triggered cancer cell death in triple-negative breast cancer — one of the most difficult-to-treat forms — through a targeted oxidative mechanism.
PubMed
Myricetin was shown to reduce the spread (metastasis) of breast cancer cells by blocking the enzymes that allow tumors to invade surrounding tissue.
ER+ Breast Cancer
PubMed
Myricetin inhibited a key enzyme that drives the growth of estrogen receptor-positive (ER+) breast cancer cells, pointing to its potential as a natural chemopreventive agent.
Lung Cancer
PubMed
Ampelopsin (Myricetin from Moyeam) induced programmed cell death in human lung cancer cells by disrupting the structural machinery cancer cells use to divide.
Glioma / Brain Cancer
PubMed
Ampelopsin (Myricetin) triggered cancer cell death in human brain tumor (glioma) cells through multiple simultaneous pathways, showing strong anticancer activity.
Anti-Metastatic (Cancer Spread)
PubMed
Myricetin reduced the ability of bile duct cancer cells to migrate and invade surrounding tissue, directly inhibiting cancer metastasis.
Hypertension
PubMed
Myricetin was shown to significantly lower blood pressure and improve metabolic markers in an animal model of diet-induced hypertension.
PubMed
In a second hypertension model, myricetin again demonstrated a meaningful blood pressure-lowering effect, reinforcing its potential as a natural antihypertensive.
Rheumatoid Arthritis / Osteoporosis
PubMed
Dihydromyricetin protected against bone loss by suppressing the cells responsible for bone breakdown — relevant to both osteoporosis and arthritis-related joint deterioration.
Dementia / Parkinson's Disease
PubMed
Dihydromyricetin was shown to block and even reverse the protein clumping (α-synuclein aggregation) that is a hallmark of Parkinson's disease, protecting brain neurons from damage.
Type 2 Diabetes
PubMed
In a human clinical study, Moyeam supplementation measurably improved blood sugar control in type 2 diabetes patients — a rare and significant human trial result.
PubMed
Beyond blood sugar, Dihydromyricetin was found to protect the brain from the cognitive decline associated with type 2 diabetes, reducing oxidative stress and boosting neuroprotective factors.
Acute Pancreatitis
PubMed
Dihydromyricetin suppressed the inflammatory cascade responsible for acute pancreatitis, reducing pancreatic tissue damage in an experimental model.
Ulcerative Colitis
PubMed
A comprehensive pharmacological study found that Moyeam (Ampelopsis grossedentata) exerted significant anti-inflammatory effects on colitis, helping to protect and heal the colon lining.
Skin Health
PubMed
Myricetin reduced the inflammatory responses in skin cells that trigger acne breakouts, supporting its use as a topical and dietary skin treatment.
Muscle Atrophy
PubMed
Dihydromyricetin counteracted steroid-induced muscle wasting by restoring mitochondrial health in muscle cells — relevant for athletes and those recovering from illness or medication.
Acute Lung Injury
PubMed
Dihydromyricetin significantly reduced lung inflammation and tissue damage in an acute lung injury model, pointing to its potential value in respiratory conditions.
Sleep / Cardiovascular
PubMed
This study on a closely related flavonoid (gossypetin) demonstrated protective cardiovascular and cellular regenerative effects, supporting the broader flavonol family's health role.
PubMed
Gossypetin (structurally related to myricetin) was shown to prevent LDL cholesterol oxidation and the foam cell formation that causes arterial plaque.
Brain Protection
PubMed
Dihydromyricetin protected brain function and reduced inflammation caused by lead toxicity, demonstrating a neuroprotective effect against heavy metal poisoning.
Disclaimer: The research cited above is provided for educational purposes only and reflects the findings of independent researchers. Pureami Tea Company does not claim that Moyeam diagnoses, treats, cures, or prevents any disease. These statements have not been evaluated by the FDA. Consult your healthcare provider before making any changes to your diet or supplement regimen.